Explore evidence

26.8 %The lipoarabinomannan antigen (LAM) test registered a sensitivity of 26.8% for tuberculosis diagnosis among people living with HIV in Nairobi, Kenya.

Kenyatuberculoseobserved 2022-2023published 2024PloS onePubMeddocument of 7 observations

4.5 %Mortality was 4.5% amongst bacteriologically confirmed TB patients.

Kenyatuberculosepublished 2021Scientific reportsPubMeddocument of 12 observations

0.3 %Gatifloxacin resistance among HIV-negative tuberculosis patients in Western Kenya was 0.3%.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 23 observations

90 %Among smear-positive pulmonary tuberculosis/HIV co-infected patients in Kenya between 2012 and 2015, 90% had a treatment outcome of cured.

Kenyatuberculose · VIH/sidaobserved 2012-2015published 2020PloS onePubMeddocument of 6 observations

33.3 yearsThe mean age of the 9,026 smear-positive pulmonary tuberculosis/HIV co-infected patients aged 15–49 years in Kenya between 2012 and 2015 was 33.3 years.

Kenyatuberculose · VIH/sidaobserved 2012-2015published 2020PloS onePubMeddocument of 6 observations

15.6 %The yield of active tuberculosis in internally-displaced persons camps was 15.6%.

Kenyatuberculosepublished 2022Tuberculosis research and treatmenteurope_pmcdocument of 8 observationsDOI 10.1155/2022/9947068

267.4 per_100000The median TB case notification rate among individuals aged ≥15 years in Kenya was 267.4 per 100,000 in 2015.

Kenyatuberculoseobserved 2015published 2018BMC infectious diseaseseurope_pmcdocument of 12 observations

20 %Twenty percent of participants had confirmed tuberculosis.

Kenyatuberculosepublished 2022PloS onePubMeddocument of 10 observations

In 2010–14, HIV or tuberculosis was the top cause of death among adults aged 20–59 years.

Kenyatuberculose · VIH/sidaobserved 2010–14published 2024The Lancet. Global healthPubMeddocument of 6 observations

32 %The proportion of HIV-infected TB patients declined from 32% in 2012 to 24% in 2020.

Kenyatuberculose · VIH/sidaobserved 2012–2020published 2023BMC infectious diseasesPubMeddocument of 11 observations

3.5 %TB case fatality among HIV-negative people in Kenya rose from 3.5% in 2008 to 3.9% in 2018.

Kenyatuberculose · VIH/sidaobserved 2008published 2022The international journal of tuberculosis and lung disease : the official journal of the IPubMeddocument of 8 observations

31.5 %Prevalence of Mtb-specific responses was similar regardless of HIV exposure (HIV exposed, 31.5%; HIV unexposed, 25.5%).

Kenyatuberculosepublished 2026The Journal of infectious diseasesPubMeddocument of 4 observations

Mtb-cfDNA signal decreased after tuberculosis treatment initiation, with near or complete Mtb-cfDNA clearance by 6 months after tuberculosis treatment initiation.

Kenyatuberculoseobserved 6 months after tuberculosis treatment initiationpublished 2022The Lancet. MicrobePubMeddocument of 6 observations

87.8 %542 (87.8%) of the 617 participants were negative for presumptive Mycobacterium tuberculosis.

Kenyatuberculoseobserved July 2021 to June 2022published 2023Ethiopian journal of health sciencesPubMeddocument of 9 observations

95 %Uptake of antiretroviral therapy among TB/HIV co-infected patients was 95%.

Kenyatuberculose · VIH/sidaobserved 2012–2020published 2023BMC infectious diseasesPubMeddocument of 11 observations

81.3 %Buccal swab specificity was 81.3% versus sputum Xpert and culture.

Kenyatuberculosepublished 2022PloS onePubMeddocument of 10 observations

3.4 %Rhizopus spp. were isolated from 3 out of 88 fungal-positive sputum samples (3.4%) among PTB patients in Kenya.

Kenyatuberculosepublished 2022BMC infectious diseasesPubMeddocument of 14 observations

81.6 %Out of the 201 eligible presumptive TB patients, 164 (81.6%) did not return at 2 weeks for follow up.

Kenyatuberculoseobserved February 2013 to February 2014published 2019African Journal of Health SciencesOpenAlexdocument of 5 observations

42 %Among 10,328 eligible adolescents and young adults living with HIV in Kenyan HIV clinics, 4337 (42.0%) initiated tuberculosis preventive therapy.

Kenyatuberculosepublished 2023Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 6 observations

11,339 patients11,339 (88%) of the included TB patients had pulmonary TB.

Kenyatuberculoseobserved 2012 to 2018published 2021Scientific reportsPubMeddocument of 12 observations

9.9 %Mortality was 9.9% amongst clinically diagnosed TB patients.

Kenyatuberculosepublished 2021Scientific reportsPubMeddocument of 12 observations

45 %HIV-coinfection among TB cases in Kenya declined from 45% in 2008 to 27% in 2018.

Kenyatuberculose · VIH/sidaobserved 2008published 2022The international journal of tuberculosis and lung disease : the official journal of the IPubMeddocument of 8 observations

15.2 %Tuberculosis was confirmed in 87 (15.2%) of 574 enrolled HIV-positive adult patients.

Kenyatuberculose · VIH/sidapublished 2021International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument of 10 observations

58.2 %Out of 426 tuberculosis suspects, 58.2% had delayed in seeking medical care.

Kenyatuberculosepublished 2012DOAJ (DOAJ: Directory of Open Access Journals)OpenAlexdocument of 2 observations

0.9 %The prevalence of pulmonary tuberculosis was 0.9% among IPT-treated people living with HIV in western Kenya.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 12 observations